Evolve Private Wealth LLC purchased a new position in shares of Blue Bird Corporation (NASDAQ:BLBD – Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 10,234 shares of the company’s stock, valued at approximately $808,000.
Several other institutional investors have also recently added to or reduced their stakes in BLBD. HighTower Advisors LLC grew its position in Blue Bird by 24.6% in the 4th quarter. HighTower Advisors LLC now owns 83,508 shares of the company’s stock valued at $3,925,000 after buying an additional 16,501 shares during the last quarter. Jefferies Financial Group Inc. raised its position in Blue Bird by 279.7% during the 4th quarter. Jefferies Financial Group Inc. now owns 21,540 shares of the company’s stock worth $1,012,000 after buying an additional 15,867 shares during the last quarter. UBS Group AG raised its position in Blue Bird by 161.7% during the 4th quarter. UBS Group AG now owns 277,796 shares of the company’s stock worth $13,056,000 after buying an additional 171,642 shares during the last quarter. Vanguard Group Inc. lifted its stake in shares of Blue Bird by 7.1% in the 4th quarter. Vanguard Group Inc. now owns 2,041,085 shares of the company’s stock worth $95,931,000 after acquiring an additional 135,562 shares during the period. Finally, Royce & Associates LP boosted its holdings in shares of Blue Bird by 9.3% in the fourth quarter. Royce & Associates LP now owns 177,924 shares of the company’s stock valued at $8,362,000 after acquiring an additional 15,107 shares in the last quarter. Institutional investors and hedge funds own 93.59% of the company’s stock.
Blue Bird Price Performance
Shares of NASDAQ:BLBD opened at $61.89 on Monday. The firm has a market capitalization of $1.96 billion, a price-to-earnings ratio of 7.53, a price-to-earnings-growth ratio of 0.80 and a beta of 1.36. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.64 and a quick ratio of 0.67. The business’s 50 day simple moving average is $73.68 and its 200-day simple moving average is $66.03. Blue Bird Corporation has a 12 month low of $46.14 and a 12 month high of $83.39.
Analyst Ratings Changes
Several research firms recently issued reports on BLBD. Barclays increased their price target on shares of Blue Bird from $75.00 to $85.00 and gave the stock an “overweight” rating in a report on Monday, July 20th. Needham & Company LLC reaffirmed a “buy” rating and issued a $86.00 price objective on shares of Blue Bird in a report on Thursday, August 6th. Roth Capital set a $93.00 target price on Blue Bird in a research report on Monday, August 10th. BTIG Research increased their target price on Blue Bird from $80.00 to $95.00 and gave the stock a “buy” rating in a research note on Thursday, August 6th. Finally, Wall Street Zen raised Blue Bird from a “hold” rating to a “buy” rating in a report on Saturday. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat.com, Blue Bird currently has a consensus rating of “Buy” and a consensus price target of $85.33.
View Our Latest Stock Report on BLBD
Blue Bird Profile
Blue Bird Corporation (NASDAQ: BLBD) is a leading manufacturer of buses and mass transportation vehicles headquartered in Fort Valley, Georgia. The company’s core business encompasses the design, engineering, and production of school buses and activity buses, with a product lineup that includes conventional (Type C) models, transit-style (Type D) models and specialty configurations for special-needs and activity transport. In recent years, Blue Bird has expanded its offerings to include zero-emission electric school buses, reflecting its commitment to advanced propulsion technologies and environmental sustainability.
Established in 1927, Blue Bird has built a legacy of safety and reliability in student transportation.
See Also
- Five stocks we like better than Blue Bird
- VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You?
- 3 Closed-End Funds to Maximize Dividend Payments
- Rocket Lab’s Sell-Off Is Fading—Is It Finally Safe to Buy?
- $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over
Receive News & Ratings for Blue Bird Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Blue Bird and related companies with MarketBeat.com's FREE daily email newsletter.
